Exicure

Exicure is an Illinois-based biotechnology company that researches and develops nucleic acid therapeutics for the treatment of neurological diseases and genetic disorders.

Business Model:

Revenue: $5.7M

Employees: 11-50

Detailed Exicure Information

Geographic Data

Exicure headquarters map

Address: 2430 N. Halsted Street

City: Chicago

State: IL

Zip: 60614

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$12M

Raised Total:

$105M

Metrics

4,309,315Website Global Rank

2,656Website Monthly Traffic

Twitter Followers

Description

Exicure is an Illinois-based biotechnology company that researches and develops nucleic acid therapeutics for the treatment of neurological diseases and genetic disorders.

Contact Phone:
+18476731700

Contact Email:

Exicure went public on 12/19/2019 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
12/19/2019

Ticker Symbol:
XCUR

IPO Price:
$2.75/share

Amount Raised:
$28M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
8/2018 Venture Round $22M
2/2015 Series C $4.5M
12/2009 Series A $2.5M
12/2021 Post-IPO Equity $11.5M
1/2016 Series C 1 - Acequia Capital (AceCap)
Acequia Capital (AceCap)
10/2015 Venture Round 2 $14.8M Tempus
Liz Lefkofsky
7/2013 Series B 1 - AbbVie Biotech Ventures
AbbVie Biotech Ventures
5/2022 Private Placement $5M
9/2022 Post-IPO Equity 1 $5.4M CBI USA
CBI USA
6/2014 Series C 4 $13.6M Patrick Ryan
Craig Mundie
Boon Hwee Koh
Bill Gates
12/2011 Series B 5 $5.4M Patrick Ryan
Eric Schmidt
David R. Walt
Craig Mundie
Abbott Biotech Ventures
11/2017 Private Placement 4 $11.2M Luye Pharma
HT Capital
Alumni Ventures
Knoll Capital Management
Luye Pharma
HT Capital
Alumni Ventures
Knoll Capital Management
Luye Pharma
9/2017 Private Placement $20.8M
9/2017 Venture Round $0 Tempus
AbbVie Biotech Ventures
Katalyst Securities
David R. Walt
Craig Mundie
Mark Tompkins
Patrick G. Ryan
Tempus
AbbVie Biotech Ventures
Katalyst Securities
David R. Walt
Craig Mundie
Mark Tompkins
Patrick G. Ryan
9/2017 Venture Round 7 $20M AbbVie Biotech Ventures
Katalyst Securities
David R. Walt
Tempus
Craig Mundie
Mark Tompkins
AbbVie Biotech Ventures
Katalyst Securities
David R. Walt
Tempus
Craig Mundie
Mark Tompkins
1/2016 Series C 1 -
7/2013 Series B 1 - AbbVie Biotech Ventures
AbbVie Biotech Ventures
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research